SAGE Open Medical Case Reports (Jun 2023)

Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism

  • Sofia De Taddeo,
  • Aikaterini Andreadi,
  • Alessandro Minasi,
  • Ilenia D’Ippolito,
  • Barbara Borelli,
  • Marco Meloni,
  • Maria Romano,
  • Valeria Ruotolo,
  • Laura Cacciotti,
  • Giuseppe Rizzo,
  • Lodovico Patrizi,
  • Alfonso Bellia,
  • Davide Lauro

DOI
https://doi.org/10.1177/2050313X231178404
Journal volume & issue
Vol. 11

Abstract

Read online

Hyperandrogenism during menopause is often underestimated by clinicians and attributed to the natural aging process. Hyperandrogenism can be associated with some metabolic abnormalities linked together in a vicious circle by insulin resistance. We present the case of an elderly woman affected with type 2 diabetes and obesity who reported the occurrence of clinical hirsutism after physiological menopause at the age of 47 years. At presentation, physical examination and Ferriman-Gallwey score revealed a condition of moderate hirsutism, with markedly increased levels of plasma testosterone and delta-4-androstenedione, obesity (body mass index 31.9), and inadequate glycemic control (glycated hemoglobin 65 mmol/mol). The patient underwent a thorough differential diagnosis by a multidisciplinary team approach, including the various causes of hyperandrogenism during menopause. After choosing surgical option as the appropriate treatment, clinical resolution of hirsutism was observed alongside patient satisfaction and marked improvement of the glucometabolic profile.